Expert Testimony
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
Adult Use (cannabis)
date
11/16/23
Expert Testimony
Opposing Maryland HB 23-1147: Cannabis-Induced Psychosis and THC Concentration Limit
Medical (cannabis)
date
3/1/23
Expert Testimony
Doctors for Drug Policy Reform Provides Testimony on Hawaii SB375
Adult Use (cannabis)
date
2/17/23
D4DPR Updates
D4DPR Publishes White Paper on Legislating Cannabis Use in Healthcare Facilities
Medical (cannabis)
date
2/17/23
Expert Testimony
Expert Testimony Not Required for Colorado Senate Bill 081
Medical (cannabis)
date
2/17/23
Expert Testimony
D4DPR's Maryland Spokesperson Submits Written Testimony for General Assembly Committee In Support of HB556
Medical (cannabis)
date
2/16/23
Expert Testimony
Supporting Delaware HB 23-2-The Delaware Marijuana Control Act
Adult Use (cannabis)
date
1/24/23
Expert Testimony
Kansas Senate Bill SB 560
Medical (cannabis)
date
6/29/22
Expert Testimony
D4DPR Calls for Delaware Veto Override of HB 371 - Cannabis Legalization
Adult Use (cannabis)
date
6/2/22
Expert Testimony
D4DPR Letter to the House in Strong Support of the MORE Act
date
2/24/22
Expert Testimony
Delaware House Health and Human Development Committee HB 305
Adult Use (cannabis)
date
1/26/22
Expert Testimony
D4DPR Letter to the House in Support of the MORE Act
date
10/1/21
Expert Testimony
New Jersey Cannabis Regulatory Commission: High potency THC, Edibles
Regulatory (cannabis)
date
6/2/21
Expert Testimony
Colorado House Public & Behavioral Health & Human Services HB21-1317
Regulatory (cannabis)
date
5/18/21
Expert Testimony
Alabama House SB46
Medical (cannabis)
date
4/26/21
Expert Testimony
Texas House Criminal Jurisprudence Committee HB3772
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
4/20/21
Expert Testimony
Delaware House Human Health Committee HB150
Adult Use (cannabis)
Bryon Adinoff, MD
date
3/24/21
Expert Testimony
Delaware House Human Health Committee HB150
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/24/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Regulatory (cannabis)
Hugh Blumenfeld, MD, PhD
date
3/1/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Adult Use (cannabis)
Bryon Adinoff, MD
date
2/25/21
Expert Testimony
New York Legislature CRTA
Medical (cannabis)
Tanya Adams, DO
date
2/23/21
Expert Testimony
New Jersey Senate Judiciary AB1898
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
2/22/21
Expert Testimony
Virginia Senate: Adult Use Cannabis
Adult Use (cannabis)
Bryon Adinoff, MD
date
1/31/21
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
Adult Use (cannabis)
date
1/1/21
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
Regulatory (cannabis)
date
1/1/21
Expert Testimony
New Jersey Assembly Appropriations: Regulations
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
11/20/20
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
11/10/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use (cannabis)
Bryon Adinoff, MD
date
3/3/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/3/20
Expert Testimony
US House Subcommittee Cannabis Policies for the New Decade
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
1/18/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
New Jersey General Assembly CR840
Monica Taing, PharmD
date
12/12/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Bryon Adinoff, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Wendy Askew, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Rachel Knox, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Genester Wilson-King, MD, FACOG
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Donald O. Lyman, MD, DTPH
date
10/23/19
Expert Testimony
U.S. House: Congressional Committee Hearing on Cannabis Legalization
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
7/10/19
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use (cannabis)
Bryon Adinoff, MD
date
6/5/19
Expert Testimony
Colorado Senate Medical Marijuana Code SB218
Medical (cannabis)
date
5/10/19
Expert Testimony
Vermont House Government Operations SB54
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/30/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical (cannabis)
Bryon Adinoff, MD
date
4/6/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical (cannabis)
date
4/1/19
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/19/19
Expert Testimony
Texas House Public Health HB1365
Medical (cannabis)
Bryon Adinoff, MD
date
3/16/19
Expert Testimony
Texas House Criminal Jurisprudence HB63
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
3/4/19
Expert Testimony
Vermont Senate Judiciary SB54
David L. Nathan, MD, DFAPA
date
2/1/19
Expert Testimony
New York General Assembly
Adult Use (cannabis)
date
12/1/18
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use (cannabis)
date
11/1/18
Expert Testimony
New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
10/17/18
Expert Testimony
Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)
David L. Nathan, MD, DFAPA
date
4/30/18
Expert Testimony
New Jersey Division of Consumer Affairs Marijuana Reclassification
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/25/18
Expert Testimony
U.S. FDA Cannabis Scheduling
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/23/18
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization
David L. Nathan, MD, DFAPA
date
3/6/18
Expert Testimony
Illinois General Assembly SB316
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
1/23/18
Expert Testimony
Testimony before the Illinois Senate on Marijuana Legalization
date
1/22/18
Expert Testimony
New Jersey Senate Judiciary Cannabis Adult Use
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
6/19/17
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
5/11/17
Expert Testimony
Texas House Criminal Jurisprudence HB2107
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
5/3/17
Expert Testimony
California State Assembly AB1606
Regulatory (cannabis)
D4DPR
date
4/14/17
Expert Testimony
Vermont House Human Services H.170
Adult Use (cannabis)
Bryon Adinoff, MD
date
4/12/17
Expert Testimony
Rhode Island House Judiciary HB5555
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
4/12/17
Expert Testimony
Texas House Criminal Jurisprudence HB81
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
3/14/17
Expert Testimony
New Jersey Senate Judiciary
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
11/17/15

Browse by Location

Alabama
California
Colorodo
Connecticut
Delaware
Federal
Hawaii
Illinois
International
Kansas
Maryland
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia

Browse by Topic

Opioids
Harm Reduction
Psychedelics
Penalty Reduction (cannabis)
Regulatory (cannabis)
Medical (cannabis)
Adult Use (cannabis)